Immunyx Pharma Part of Global Consortium CanceRNA Developing RNA-based Cancer Vaccine
Immunyx Pharma is member of CanceRNA , a global consortium applying RNA-based therapeutics to successfully unlock anti-cancer immune responses. The consortium is led by Professor Michal Lotem, MD, Head of…
Continue Reading
Immunyx Pharma Part of Global Consortium CanceRNA Developing RNA-based Cancer Vaccine